Methods for a public health response to birth defects clusters

Teratology

Volumn 66, Issue SUPPL. 1, 2002, Pages

  Williams, Laura J ^a,b   Honein, Margaret A ^a   Rasmussen, Sonja A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b The National Center on Birth Defects   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HUMAN; INCIDENCE; MEDICAL RECORD; METHODOLOGY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE;

ABNORMALITIES; CLINICAL PROTOCOLS; CLUSTER ANALYSIS; DATA COLLECTION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERVIEWS; MOTHERS; PUBLIC HEALTH; PUBLIC POLICY; REGISTRIES; UNITED STATES;

EID: 0036388897     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.90011     Document Type: Article

References (31)

1. th ed. Elk Grove Village, IL: American Academy of Pediatrics. p 210, 438.
2. Alderman BW, Fernbach SK, Greene C, Mangione EJ, Ferguson SW. 1997. Diagnostic practice and the estimated prevalence of craniosynostosis in Colorado. Arch Pediatr Adolesc Med 151:159-164.
3. Bender AP, Williams AN, Johnson RA, Jagger HG. 1990. Appropriate public health responses to clusters: the art of being responsibly responsive. Am J Epidemiol 132 (1 Suppl):S48-52.
4. Beral V. 1990. Childhood leukemia near nuclear plants in the United Kingdom: the evolution of a systematic approach to studying rare disease in small geographic areas. Am J Epidemiol 132 (1 Suppl): S63-68.
5. Caldwell GG. 1990. Twenty-two years of cancer cluster investigations at the Centers for Disease Control. Am J Epidemiol 132 (1 Suppl): S43-47.
6. CDC. 1981. Pneumocystis pneumonia-Los Angeles. Morb Mortal Wkly Rep 30:250-252.
7. CDC. 1987. Cluster of craniosynostosis-Colorado. Atlanta, Ga: Division of Birth Defects and Developmental Disabilities, Center for Environmental Health and Injury Control, Public Health Service publication EPI-83-56-2.
8. CDC. 1990. Guidelines for investigating clusters of health events. Morb Mortal Wkly Rep 39(RR-11):1-16.
9. CDC. 2001. Cancer clusters. http://www.cdc.gov/cancer/npcr/clusters.htm.
10. De Wals P. 1999. Investigation of clusters of adverse reproductive outcomes, an overview. Eur J Epidemiol 15:871-875.
11. Dolk H. 1999. The role of assessment of spatial variation and clustering in environmental surveillance of birth defects. Eur J Epidemiol 15:839-945.
12. Fiore BJ, Hanrahan LP, Anderson HA. 1990. State health department response to disease cluster reports: a protocol for investigation. Am J Epidemiol 132 (1 Suppl):S14-22.
13. Fraser DW, Tsai RT, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, et al. 1977. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 297:1189-1197.
14. Goujard J. 1999. Clusters of birth defects: emergency and management. A review of some publications. Eur J Epidemiol 15:853-862.
15. Herbst AL, Ulfelder H, Poskanzer DC. 1971. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881.
16. Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, et al. 1999. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 354:2101-2105.
17. Khoury MJ, Holtzman NA. 1987. On the ability of birth defects monitoring to detect new teratogens. Am J Epidemiol 126:136-143.
18. Lubinsky MS. 1997. Association of prenatal vascular disruptions with decreased maternal age. Am J Med Genet 69:237-239.
19. Lynberg MC, Edmonds LD. 1992. Surveillance of birth defects. In: Halperin W, Baker EL, eds. Public Health Surveillance. New York, NY: Van Nostrand Reinhold; p 157.
20. McBride WG. 1963. The teratogenic action of drugs. Med J Aust 2:689-695.
21. NBDPN. 2001. www.NBDPN.org.
22. Olsen SF, Martuzzi M, Elliott P. 1996. Cluster analysis and disease mapping - Why, when, and how? A step by step guide. BMJ 313: 863-866.
23. Osborne JS III, Shy CM, Kaplan BH. 1990. Epidemiologic analysis of a reported cancer cluster in a small rural population. Am J Epidemiol 132 (1 Suppl):S87-95.
24. Polifka JE, Friedman JM. 1999. Clinical teratology: identifying teratogenic risks in humans. Clin Genet 56:409-420.
25. Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Khoury MJ. 1995. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics 96:880-883.
26. Rothman KJ, Greenland S. 1998. Modern Epidemiology. Pennsylvania: Lipincott-Raven Publishers. p 186.
27. Texas Birth Defects Monitoring Division (TBDMD). 1999. Birth defect cluster investigation protocol. Texas Department of Health.
28. Turnbull BW, Iwano EJ, Burnett WS, Howe HL, Clark LC. 1990. Monitoring for clusters of disease: application to leukemia incidence in upstate New York. Am J Epidemiol 132 (1 Suppl):S136-143.
29. Williams AN, Johnson RA, Bender AP. 1990. Use of coded mortality data to assess area cancer rates: impact of residence reporting and coding errors. Am J Epidemiol 132 (1 Suppl):S178-182.
30. Wynne JW, Harris J, Bentley S, Stierman L. 1999. Investing birth defects clusters: a systematic approach. California Birth Defects Monitoring Program.
31. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, et al. The National Birth Defects Prevention Study. Public Health Rep 2001; 116(1 Suppl):32-40.